Public health authorities in England have launched a vaccination campaign targeting approximately one million young people with a free meningitis B vaccine. The initiative follows an outbreak in Kent in March that resulted in 29 confirmed or suspected cases and two deaths, which officials characterized as unprecedented and explosive.
The vaccine is being offered to 17 and 18-year-olds in sixth form and students under age 25 entering residential universities or further education colleges for the first time this autumn. Eligible individuals include those born between 1 September 2007 and 31 August 2008, as well as students born on or after 21 July 2001 who are beginning higher education. International students and those from other parts of the UK studying in England are also included. Nearly 90,000 doses have already been administered, with 135,000 more scheduled for upcoming weeks.
The vaccine requires two doses administered at least 28 days apart for optimal protection. Both doses are necessary for fullest protection against meningitis B, a dangerous bacterial strain that can cause severe complications. The vaccine does not contain live bacteria and cannot cause meningitis itself. Common side effects include mild reactions at the injection site and temporary symptoms such as low fever, nausea, or headache, typically resolving within one to two days. Serious adverse effects are rare.
Registered 17 and 18-year-olds can book appointments through the NHS National Booking Service, while other eligible students can contact participating pharmacies. Walk-in vaccination services are available at high street pharmacies for those born on or after 21 July 2001 who do not need to be registered with a general practitioner. Meningitis B infection poses particular risk to first-year university students, whose infection rates are approximately seven times higher than similarly aged peers not attending university, largely due to close contact in shared accommodation and social mixing.
Meningitis B can cause life-threatening conditions including brain inflammation and sepsis, potentially resulting in permanent disabilities such as hearing loss, amputation, or brain damage. UK vaccine experts have recommended that government consider routinely offering the vaccine to all teenagers around age 15, though decisions on broader implementation remain with individual ministers across the nations.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI